Jennifer Blain Christen

Dr. Jennifer Blain Christen

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2018 in Proteomics – Clinical Applications
Verified
Journal Article
Open access
PDF file
BKBenjamin A. Katchman
Benjamin A. Katchman
MZMeilin Zhu
Meilin Zhu
JCJennifer Blain Christen
Jennifer Blain Christen
KAKaren S. Anderson
Karen S. Anderson
Purpose: Sweat is a relatively unexplored biofluid for diagnosis and monitoring of disease states. In this study, the proteomic profiling of immune‐related biomarkers from healthy individuals are presented.Experimental Design: Eccrine sweat samples are collected from 50 healthy individuals. LC‐MS/MS is performed on two pools of sweat samples from five male and female participants. Individual sweat samples are analyzed by antibody isotyping microarrays (n = 49), human cytokine arrays (n = 30), and quantitative ELISAs for interleukin‐1α (n = 16), epidermal growth factor (n = 6), and angiogenin (n = 7).Results: In sweat, 220 unique proteins are identified by shotgun analysis. Detectable antibody isotypes include IgA (100% positive; median 1230 ± 28 700 pg mL−1), IgD (18%; 22.0 ± 119 pg mL−1), IgG1 (96%; 1640 ± 6750 pg mL−1), IgG2 (37%; 292 ± 6810 pg mL−1), IgG3 (71%; 74.0 ± 119 pg mL−1), IgG4 (69%; 43.0 ± 42.0 pg mL−1), and IgM (41%; 69.0 ± 1630 pg mL−1). Of 42 cytokines, three are readily detected in all sweat samples (p < 0.01). The median concentration for interleukin‐1α is 352 ± 521 pg mL−1, epidermal growth factor is 86.5 ± 147 pg mL−1, and angiogenin is 38.3 ± 96.3 pg mL−1. Multiple other cytokines are detected at lower levels.Conclusions and Clinical Relevance: Sweat can be used for profiling antibodies and innate immune biomarkers.

2 July 2007 in IEEE Transactions on Biomedical Circuits and Systems
Verified
Journal Article
Closed access
JCJennifer Blain Christen
Jennifer Blain Christen
AAAndreas G. Andreou
Andreas G. Andreou
We discuss the design, fabrication, and testing of a hybrid microsystem for stand-alone cell culture and incubation. The micro-incubator is engineered through the integration of a silicon CMOS die for the heater and temperature sensor, with multilayer silicone (PDMS) structures namely, fluidic channels and a 1.5-mm diameter 12-muL culture well. A 90-mum-thick PDMS membrane covers the top of the culture well, acting as barrier to contaminants while at the same time allowing the cells to breath and exchange gases with the ambient environment. The packaging for the microsystem includes a flexible polyimide electronic ribbon cable and four fluidic ports that provide external interfaces to electrical energy, closed-loop sensing and electronic control as well as solid and liquid supplies. The complete structure has a size of (2.5times2.5times0.6) cm3. We have employed the device to successfully culture BHK-21 cells autonomously over a three day period in ambient environment

1 October 2018 in Biosensors and Bioelectronics
Verified
Journal Article
Open access
UOUwadiae Obahiagbon
Uwadiae Obahiagbon
JSJoseph T. Smith
Joseph T. Smith
MZMeilin Zhu
Meilin Zhu
BKBenjamin A. Katchman
Benjamin A. Katchman
HAHany Arafa
Hany Arafa
JCJennifer Blain Christen
Jennifer Blain Christen
An effective method of combating infectious diseases is the deployment of hand-held devices at the point-of-care (POC) for screening or self-monitoring applications. There is a need for very sensitive, low-cost and quantitative diagnostic devices. In this study, we present a low-cost, multiplexed fluorescence detection platform that has a high sensitivity and wide dynamic range. Our system features inexpensive 3 × 3 mm interference filters with a high stopband rejection, sharp transition edges, and greater than 90% transmission in the passband. In addition to the filters, we improve signal-to-noise ratio by leveraging time for accuracy using a charge-integration-based readout. The fluorescence sensing platform provides a sensitivity to photon flux of ∼1×104photons/mm2sec and has the potential for 2-3 orders of magnitude improvement in sensitivity over standard colorimetric detection that uses colored latex microspheres. We also detail the design, development, and characterization of our low-cost fluorescence detection platform and demonstrate 100% and 97.96% reduction in crosstalk probability and filter cost, respectively. This is achieved by reducing filter dimensions and ensuring appropriate channel isolation in a 2 × 2 array configuration. Practical considerations with low-cost interference filter system design, analysis, and system performance are also discussed. The performance of our platform is compared to that of a standard laboratory array scanner. We also demonstrate the detection of antibodies to human papillomavirus (HPV16) E7 protein, as a potential biomarker for early cervical cancer detection in human plasma.

26 February 2014 in Journal of Display Technology
Verified
Journal Article
Closed access
JSJoseph T. Smith
Joseph T. Smith
BOBarry O'Brien
Barry O'Brien
YLYong-Kyun Lee
Yong-Kyun Lee
EBEdward J. Bawolek
Edward J. Bawolek
JCJennifer Blain Christen
Jennifer Blain Christen
This paper presents a new biophotonic application for large-area, high-resolution, flexible organic light-emitting diode (OLED) display technology currently used to manufacture low-cost color flexible displays on plastic substrates. The new concept uses a fully addressable high resolution flexible OLED pixel array on a thin, mechanically compliant biocompatible plastic substrate to selectively stimulate and/or silence small groups of neurons on either the cortical surface or, alternatively, within the deep brain. Optical measurements from a 455 nm blue flexible OLED test structure demonstrated the ability to emit 1 mW/mm 2 of instantaneous light intensity using a 13 V, 20 Hz pulse, which meets the minimum reported intensity at ~ 450 nm to induce optical stimulation in genetically modified neural tissue. Biocompatibility was successfully demonstrated by the ability to grow human epithelial cells on the surface of a full TFT process flow plastic flexible display substrate. Additionally, a new active matrix array display architecture was designed to support pulsed mode OLED operation. These preliminary results demonstrate the initial viability of extending flexible plastic substrate OLED display technology to the development of large-area, high-resolution emissive active matrix arrays for chronic optogenetic applications.

25 January 2013 in Journal of Micromechanics and Microengineering
Verified
Journal Article
Closed access
DWDavid Welch
David Welch
JCJennifer Blain Christen
Jennifer Blain Christen

16 September 2015 in Journal of Display Technology
Verified
Journal Article
Closed access
JSJoseph T. Smith
Joseph T. Smith
BKBenjamin A. Katchman
Benjamin A. Katchman
DKDixie E. Kullman
Dixie E. Kullman
UOUwadiae Obahiagbon
Uwadiae Obahiagbon
YLYong-Kyun Lee
Yong-Kyun Lee
JCJennifer Blain Christen
Jennifer Blain Christen
This paper presents a new concept combining flexible organic light-emitting diode (OLED) display technology with fluorescent biorecognition microarray technology to fabricate point-of-care immunobiosensors. Our approach is designed to leverage commercial OLED display technology to reduce pre-functionalized biosensor substrate costs to pennies per cm2 combined with leveraging the display industries ability to manufacture an immense number of low-cost consumer electronic products annually. For this work, we demonstrate that our new approach using high brightness flexible OLED display technology combined with a charge integrating readout circuit and optical filters can offer point-of-care diagnostic sensitivity at or below 10 pg/mL, which approaches the lower limit of detection (LLOD) of typical clinical laboratory instrumentation.